Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ginkgo Bioworks Holdings, Inc.DNA · Entity 5530 | See remarks | October 05, 2026 | October 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ginkgo Bioworks Holdings, Inc.
Report date October 05, 2026 · Filed October 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 49,448 |
Reported balance
After 2026-10-05 transaction · row 1
1 source rowRow 1 · 2026-10-05 · Sale · Disposed 2,403 · Balance 49,448 F1: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934 |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2025 Filed Oct 3, 2025 21:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 5,609 | $15.00 | $84,135.00 |
DisclosureSEC source: 0001977441-25-000008 · wk-form4_1759525267.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,503 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| August 22, 2025 Filed Aug 26, 2025 20:10 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 310 | $12.40 | $3,842.76 |
DisclosureSEC source: 0001977441-25-000006 · wk-form4_1756238998.xml · nonDerivative · entry 3 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,112 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| August 21, 2025 Filed Aug 26, 2025 20:10 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001977441-25-000006 · wk-form4_1756238998.xml · derivative · entry 5 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,847 Underlying: Class A Common Stock · 156 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. Read SEC document |
| August 21, 2025 Filed Aug 26, 2025 20:10 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001977441-25-000006 · wk-form4_1756238998.xml · derivative · entry 4 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,340 Underlying: Class A Common Stock · 587 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. Read SEC document |
| August 21, 2025 Filed Aug 26, 2025 20:10 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001977441-25-000006 · wk-form4_1756238998.xml · nonDerivative · entry 2 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| August 21, 2025 Filed Aug 26, 2025 20:10 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001977441-25-000006 · wk-form4_1756238998.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| July 17, 2025 Filed Jul 21, 2025 20:28 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 1,084 | $9.84 | $10,668.73 |
DisclosureSEC source: 0001628280-25-035462 · wk-form4_1753129687.xml · nonDerivative · entry 4 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,679 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| July 16, 2025 Filed Jul 21, 2025 20:28 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 1,061 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-035462 · wk-form4_1753129687.xml · derivative · entry 7 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,123 Underlying: Class A Common Stock · 1,061 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F5 · derivative.exercise_date: The RSUs vest as follows: 25% vested on April 16, 2025; 25% vested on July 16, 2025; 25% will vest on October 16, 2025; and 25% will vest on January 16, 2026. F5 · derivative.expiration_date: The RSUs vest as follows: 25% vested on April 16, 2025; 25% vested on July 16, 2025; 25% will vest on October 16, 2025; and 25% will vest on January 16, 2026. Read SEC document |
| July 16, 2025 Filed Jul 21, 2025 20:28 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 312 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-035462 · wk-form4_1753129687.xml · derivative · entry 6 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,003 Underlying: Class A Common Stock · 312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. Read SEC document |
| July 16, 2025 Filed Jul 21, 2025 20:28 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 1,174 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-035462 · wk-form4_1753129687.xml · derivative · entry 5 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,927 Underlying: Class A Common Stock · 1,174 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. Read SEC document |
| July 16, 2025 Filed Jul 21, 2025 20:28 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,061 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-035462 · wk-form4_1753129687.xml · nonDerivative · entry 3 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| July 16, 2025 Filed Jul 21, 2025 20:28 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 312 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-035462 · wk-form4_1753129687.xml · nonDerivative · entry 2 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| July 16, 2025 Filed Jul 21, 2025 20:28 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,174 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-035462 · wk-form4_1753129687.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 21, 2025 Filed May 22, 2025 20:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 346 | $7.59 | $2,624.41 |
DisclosureSEC source: 0001127602-25-015300 · form4.xml · nonDerivative · entry 3 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,216 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| May 20, 2025 Filed May 22, 2025 20:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-015300 · form4.xml · derivative · entry 5 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,315 Underlying: Class A Common Stock · 156 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. Read SEC document |
| May 20, 2025 Filed May 22, 2025 20:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-015300 · form4.xml · derivative · entry 4 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,101 Underlying: Class A Common Stock · 587 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. Read SEC document |
| May 20, 2025 Filed May 22, 2025 20:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-015300 · form4.xml · nonDerivative · entry 2 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,562 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 20, 2025 Filed May 22, 2025 20:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-015300 · form4.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,406 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| April 21, 2025 Filed Apr 23, 2025 21:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 997 | $7.28 | $7,261.15 |
DisclosureSEC source: 0001127602-25-012502 · form4.xml · nonDerivative · entry 4 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,819 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| April 17, 2025 Filed Apr 23, 2025 21:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 1,061 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-012502 · form4.xml · derivative · entry 7 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,184 Underlying: Class A Common Stock · 1,061 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F5 · derivative.exercise_date: The RSUs vest as follows: 25% vested on April 16, 2025; 25% will vest on July 16, 2025; 25% will vest on October 16, 2025; and 25% will vest on January 16, 2026. F5 · derivative.expiration_date: The RSUs vest as follows: 25% vested on April 16, 2025; 25% will vest on July 16, 2025; 25% will vest on October 16, 2025; and 25% will vest on January 16, 2026. Read SEC document |
| April 17, 2025 Filed Apr 23, 2025 21:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-012502 · form4.xml · derivative · entry 6 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,471 Underlying: Class A Common Stock · 156 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. Read SEC document |
| April 17, 2025 Filed Apr 23, 2025 21:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-012502 · form4.xml · derivative · entry 5 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,688 Underlying: Class A Common Stock · 587 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. Read SEC document |
| April 17, 2025 Filed Apr 23, 2025 21:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,061 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-012502 · form4.xml · nonDerivative · entry 3 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| April 17, 2025 Filed Apr 23, 2025 21:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-012502 · form4.xml · nonDerivative · entry 2 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| April 17, 2025 Filed Apr 23, 2025 21:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-012502 · form4.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,599 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | GrantRestricted Stock Units · Derivative | 4,245 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-008886 · form4.xml · derivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,245 Underlying: Class A Common Stock · 4,245 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: The RSUs vest as follows: 25% on April 16, 2025; 25% on July 16, 2025; 25% on October 16, 2025; and 25% on January 16, 2026. F2 · derivative.expiration_date: The RSUs vest as follows: 25% on April 16, 2025; 25% on July 16, 2025; 25% on October 16, 2025; and 25% on January 16, 2026. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 22:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 395 | $7.73 | $3,051.38 |
DisclosureSEC source: 0001127602-25-008565 · form4.xml · nonDerivative · entry 3 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,012 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 22:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-008565 · form4.xml · derivative · entry 5 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,627 Underlying: Class A Common Stock · 156 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 22:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-008565 · form4.xml · derivative · entry 4 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,275 Underlying: Class A Common Stock · 587 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 22:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-008565 · form4.xml · nonDerivative · entry 2 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 22:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-008565 · form4.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,251 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:52 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 367 | $13.44 | $4,933.58 |
DisclosureSEC source: 0001127602-25-003438 · form4.xml · nonDerivative · entry 3 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,664 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| February 03, 2025 Filed Feb 6, 2025 21:52 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003438 · form4.xml · derivative · entry 5 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,783 Underlying: Class A Common Stock · 156 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. Read SEC document |
| February 03, 2025 Filed Feb 6, 2025 21:52 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003438 · form4.xml · derivative · entry 4 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,862 Underlying: Class A Common Stock · 587 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. Read SEC document |
| February 03, 2025 Filed Feb 6, 2025 21:52 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003438 · form4.xml · nonDerivative · entry 2 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,031 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| February 03, 2025 Filed Feb 6, 2025 21:52 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003438 · form4.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| January 06, 2025 Filed Jan 8, 2025 22:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 324 | $11.72 | $3,796.63 |
DisclosureSEC source: 0001127602-25-001025 · form4.xml · nonDerivative · entry 3 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,288 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 03, 2025 Filed Jan 8, 2025 22:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-001025 · form4.xml · derivative · entry 5 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,939 Underlying: Class A Common Stock · 156 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. Read SEC document |
| January 03, 2025 Filed Jan 8, 2025 22:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-001025 · form4.xml · derivative · entry 4 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,449 Underlying: Class A Common Stock · 587 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. Read SEC document |
| January 03, 2025 Filed Jan 8, 2025 22:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-001025 · form4.xml · nonDerivative · entry 2 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,612 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| January 03, 2025 Filed Jan 8, 2025 22:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-001025 · form4.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 22:05 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 330 | $9.64 | $3,182.52 |
DisclosureSEC source: 0001127602-24-028729 · form4.xml · nonDerivative · entry 3 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,869 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| December 03, 2024 Filed Dec 5, 2024 22:05 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-028729 · form4.xml · derivative · entry 5 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,095 Underlying: Class A Common Stock · 156 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. Read SEC document |
| December 03, 2024 Filed Dec 5, 2024 22:05 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-028729 · form4.xml · derivative · entry 4 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,036 Underlying: Class A Common Stock · 587 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. Read SEC document |
| December 03, 2024 Filed Dec 5, 2024 22:05 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-028729 · form4.xml · nonDerivative · entry 2 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| December 03, 2024 Filed Dec 5, 2024 22:05 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-028729 · form4.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,043 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| November 04, 2024 Filed Nov 6, 2024 21:29 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 333 | $7.58 | $2,522.81 |
DisclosureSEC source: 0001127602-24-026591 · form4.xml · nonDerivative · entry 3 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,456 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 01, 2024 Filed Nov 6, 2024 21:29 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-026591 · form4.xml · derivative · entry 5 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,251 Underlying: Class A Common Stock · 156 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. Read SEC document |
| November 01, 2024 Filed Nov 6, 2024 21:29 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-026591 · form4.xml · derivative · entry 4 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,623 Underlying: Class A Common Stock · 587 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. Read SEC document |
| November 01, 2024 Filed Nov 6, 2024 21:29 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-026591 · form4.xml · nonDerivative · entry 2 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.